AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Wegovy (Novo Nordisk) (wegovy.com)
This site is a rare example of high-substance pharma communication that prioritizes clinical metrics over marketing adjectives. The bullshit levels are kept at a minimum by the gravitational pull of FDA compliance and granular trial reporting. It is a benchmark for how to market a complex biological product without resorting to hot air.
Incorporate outbound links to the specific peer-reviewed publications for the 64-week study on ClinicalTrials.gov or PubMed to move from internal proof to external validation. Add Person schema for named ambassadors to provide a verifiable digital footprint for patient stories. Reduce the repetition of the ‘Important Safety Information’ H2 blocks which appear to be a technical artifact of the crawl or site structure, cluttering the heading hierarchy.
Information density is exceptionally high for a consumer-facing site. Passages like the Wegovy pill results page provide granular data from a 64-week medical study of 307 adults, citing an average 14% body weight loss (~33 lb) and specific discontinuation rates of 18%. The ratio of power words to specific nouns is low, as most headings like ‘What is the most important information I should know?’ are functional rather than promotional fluff.
AI systems don't validate syntax — they validate identity, relationships, and meaning. Get a Clinical Structured Data Diagnosis to reveal what AI sees versus what it should see.
There is virtually zero semantic drift between the homepage signal and sub-page substance. The homepage H2 ‘Wegovy gives you options’ is directly supported by sub-pages detailing the ‘Meet the Wegovy Pill’ (25 mg tablets) and ‘Meet the Wegovy Pen’ (2.4 mg injection) with corresponding clinical data for each. Messaging remains consistent regarding age restrictions, specifically noting the pill is not approved for adolescents.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site exhibits minor trust theatre via compensated ‘Wegovy Ambassadors’ (e.g., Keytsiia, Heath, Terry) whose testimonials include efficacy claims. While review_count is high across pages (reaching 7 on the homepage), proof_links_count remains at 0 because these are internal testimonials rather than links to third-party review platforms. However, this is partially neutralized by the required legal transparency regarding patient compensation.
Proof density is high, with a strong ratio of verifiable evidence to assertions. The site provides specific starting weights (235 lb), BMI thresholds (BMI >= 30 kg/m2), and percentage-based outcomes (28% of adults lost 20% or more weight) rather than using vague adjectives like ‘transformative’ or ‘unrivaled.’
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site uses standard industry jargon such as ‘FDA approved,’ ‘mechanism of action,’ and ‘clinical trial data,’ but these are technical requirements rather than empty marketing clichés. Boilerplate sections like ‘Frequently Asked Questions’ and ‘Savings and Support’ are present but contain drug-specific answers and genuine financial assistance programs (NovoCare), preventing a high commodity penalty.
Authority is firmly established through Novo Nordisk’s corporate identity and FDA regulatory markers. While the individual ‘Ambassadors’ lack digital footprints or Person schema (scoring 2 points in authority gaps), the primary authority is the clinical evidence and manufacturer’s pharmacological standing. The technical implementation of schema (MedicalWebPage, Drug) is clean and professional.
There is no disconnect between marketing tone and demonstrated results. Claims of being the ‘only weight-loss medication proven to help reduce the risk of a major heart event’ are backed by the Cardiovascular Results sections and specific drug indications. Unlike generic health sites, every major performance claim is tethered to a specific clinical trial result.
Medical Devices, Pharma & Biotech BS: Wegovy (Novo Nordisk) (wegovy.com)
This site is a textbook match for the Pharmaceutical and Biotech industry. The content is heavily regulated, featuring mandatory Boxed Warnings, ‘Important Safety Information’ (ISI) blocks, and specific FDA-approved indications for semaglutide.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 21 is driven primarily by the 'Trust and Proof' and 'Information Density' pillars. The use of compensated ambassadors and the lack of outbound proof links to independent medical journals prevent a 'Minimal BS' score, while the high specificity of the clinical data prevents it from climbing into the 'Moderate BS' range.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 20, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Wegovy (Novo Nordisk) to view the most current version of their content and see directly what the company offers.